Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
Status:
Completed
Trial end date:
2020-04-20
Target enrollment:
Participant gender:
Summary
This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled,
parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute
uncomplicated ILI due to influenza or other respiratory viruses in a community setting.